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PERANAN STATUS PEMAKANAN DAN PETUNJUK INFLAMASI IBU 
TERHADAP PENGEKALAN BERAT BADAN POSNATAL DAN 




Emiriah Arab Bersatu (UAE) telah mengalami kepesatan ekonomi yang 
mencetuskan perubahan terhadap pemakanan dan gaya hidup,  menyebabkan 
peningkatan prevalens berat badan berlebihan dan kegemukan, terutamanya bagi 
wanita  dalam tempoh usia subur. Kehamilan adalah tempoh berisiko bagi kenaikan 
berat badan dan keradangan metabolik sistematik yang akan mempengaruhi 
penyesuaian janin pada peringkat awal kehidupan, dan berkemungkinan memberi 
kesan jangka panjang pada anak. Perspektif ini membawa kepada Kajian Kohort Ibu 
dan Bayi (MISC) yang menumpukan amalan pemakanan ibu dan bayi dan kaitannya 
dengan penanda metabolik. MISC  dijalankan selama dua tahun bermula Disember 
2015 sehingga Jun 2016 di Emirates of Sharjah, Dubai dan Ajman dari UAE. Seramai 
256 wanita Arab hamil dan sihat berusia 19 hingga 40 tahun dengan kehamilan tunggal 
direkrut semasa trimester ketiga. Peserta ditemuramah sekali semasa kehamilan, 
semasa kelahiran, pada 2 dan 6 bulan selepas kelahiran di klinik rawatan kesihatan 
primer. Data yang dikumpulkan untuk ibu termasuk ciri-ciri sosio-demografi, gaya 
hidup, pengambilan makanan, dan antropometri semasa merekrut dan semasa lawatan 
selepas bersalin manakala untuk bayi, pengukuran antropometri, dan amalan 
pemberian makanan. Sampel darah dan susu ibu dikumpulkan semasa kelahiran dari 
xvii 
ibu dan pada 6 bulan selepas bersalin untuk ibu dan bayi. Ini termasuk Gula Darah 
Berpuasa (FBS), Insulin, Profil Lipid dan Adiponektin Manusia Berat Molekul Tinggi 
(HMW); Tumor Nekrosis Faktor-alpha (TNF-α) Interleukin-6 (IL-6), dan C Reaktif 
Protein berkepekaan tinggi (hs-CRP). Selain profil susu adiponectin dan hs-CRP. 
Analisa deskriptif menunjukkan prevalens peningkatan berat badan kehamilan (GWG) 
yang ketara iaitu (39.1%) di kalangan peserta, tinggi dalam kalangan ibu berlebihan 
berat badan dan obes (53.9% dan 48.7%). Selain itu, skor indeks kualiti makanan 
peserta kurang daripada tahap optimum. Analisa regresi linear berganda (MLR) 
menunjukkan adiponektin susu (ADPN) semasa lahir berkadar negatif berbanding 
serum (hs-CRP) dan menurun 9 kali ganda dengan peningkatan 1kg dalam GWG (β = 
-9.22, p = 0.01 ). Seterusnya, MLR menunjukkan pengekalan berat badan postpartum 
(PPWR) menurun dengan peningkatan Indeks Jisim Tubuh (IJM) pra kehamilan  (β = 
-.43, p <0.01) dan meningkat dengan peningkatan GWG (β=.391, p <0.001), sementara 
hanya FBS serum parameter metabolik yang mengaitkan dengan pengekalan berat 
badan (β = 0.113, p <0.05). Serum ibu menunjukkan penurunan adiponektin ketara (p 
<0.01) dan peningkatan keradangan sitokin dan insulin yang tinggi di kalangan wanita 
obes berbanding normal. Pada usia bayi 6 bulan, penilitian skor Z parameter 
pertumbuhan, tiada perubahan signifikan  (p > 0,05) di antara amalan penyusuan yang 
berbeza (penyusuan susu ibu atau makanan campuran (MF)). Insulin serum bayi (MF) 
melebihi 3 kali ganda (9.60 µIU / ml), tahap yang direkodkan pada amalan pemberian 
makanan lain (p <0.05). Model MLR menunjukkan apabila serum BG bayi meningkat, 
diramalkan berat badan bayi lebih rendah (β = -0.024, p = 0.044). Kelahiran bayi BAZ 
dan adiponektin serum ibu adalah peramal positif bagi skor BAZ 6 bulan (β = 0.336, 
p = 0.05) dan (β = .241, p <0.05). Kesimpulannya, berat badan ibu yang berlebihan 
yang ditunjukkan dalam IJT sebelum kehamilan yang tinggi, GWG dan PPWR yang 
xviii 
berlebihan adalah petunjuk biasa bagi hasil kajian utama. Ini dianggap faktor risiko 
yang berpotensi dapat diubah umtuk menjamin pengembangan perubahan sosial dan 
perundangan yang mendasar untuk mengurangkan kesan transgenerasi kehidupan 
wanita.Walaupun manfaat penyusuan terhadap berat badan bayi merosot setelah 
penyesuaian bersama, mempromosikan penyusuan susu ibu merupakan usaha proaktif 
supaya dapat menyumbang kepada pengaturcaraan metabolik bayi terhadap obesiti 




THE ROLE OF MATERNAL NUTRITIONAL STATUS AND 
INFLAMMATORY MARKERS ON POSTNATAL WEIGHT RETENTION 
AND INFANT GROWTH FROM A COHORT STUDY (MISC) IN UNITED 
ARAB EMIRATES  
ABSTRACT 
The United Arab Emirates (UAE) has experienced rapid economic growth that 
provoked a shift in diet and lifestyle factors which triggered a marked increase in the 
prevalence of overweight and obesity particularly among women during their 
reproductive years. Pregnancy is a vulnerable period for increased weight gain and 
systematic metabolic inflammation that can dictate fetal adaptations at the earliest 
stages of the life, with possible long-lasting effects on offspring. These perspectives 
geared the initiation of Mother and Infant Study Cohort (MISC) to address maternal 
nutrition, infant feeding practices and its associations with metabolic markers. The 
current study which stems from (MISC) cohort was conducted from December 2015 
and ended in June 2016 in the Emirates of Sharjah, Dubai and Ajman of United Arab 
Emirates (UAE). A total of 256 healthy pregnant Arab women aged 19 to 40 years 
with singleton pregnancy were recruited during the third trimester of pregnancy. 
Participants were interviewed once during pregnancy, then at delivery, at two and 6 
months postpartum in the primary health care clinics. The data collected for the 
mothers included socio-demographic characteristics, lifestyle, dietary intake, and 
anthropometry upon recruitment and during the postnatal visits while for infants, 
anthropometric measurements, and feeding practices. Further, blood and breast milk 
samples were collected at birth from the mothers and at 6 months postpartum for the 
mothers and the infants. These included fasting blood sugar (FBS), insulin, lipid 
profile as well as  High Molecular Weight Human Adiponectin (HMW) ADPN; Tumor 
xx 
Necrosis Factor-alpha (TNF-α) Interleukin-6 (IL-6), and High Sensitivity C Reactive 
protein (hs-CRP). In addition to the breast milk profile of adiponectin and hs-CRP. 
Descriptive analysis revealed a marked prevalence of excessive gestational weight 
gain (GWG) (39.1%) among the participant mothers and was prominent among 
overweight and obese mothers (53.9% and 48.7%) respectively. Besides, their diet 
quality index score was less than the optimum. At 6 months, multiple linear regression 
(MLR) revealed that postpartum weight retention (PPWR) decreased with increasing 
pre pregnancy body mass index (BMI) (β=-.43, p<0.01) and increased with increasing 
gestational weight gain (GWG) (β=.391, p<0.001), while serum FBS was the only 
metabolite parameter associated with retaining weight (β= 0.113, p<0.05). The 
maternal serum demonstrated significantly (p<0.01) elevated inflammatory cytokines 
and insulin among overweight/obese women compared to leaner mothers. At 6 months 
of infants’ age, examining the Z score growth parameters, no significant changes 
(p>0.05) have been encountered among the different feeding practices (exclusive, 
predominant breast feeding or mixed feeding (MF)). The serum insulin of the (MF) 
infants significantly exceeded 3 times (9.60 µIU/ml), the recorded levels in other 
feeding practices (p< 0.05). MLR models showed that as infants’ serum BG increased, 
lower infant body weight was predicted (β=-0.024, p=0.044). Infant birth BAZ and 
maternal serum adiponectin were positive predictors for the 6 months BAZ score 
(β=0.336, p=0.05) and (β=.241, p<0.05) respectively. In conclusion, excessive 
maternal weight represented in high pre-pregnancy BMI, excessive GWG and PPWR 
was the common denominator for the major study outcomes. These considered 
potentially modifiable risk factors which warrants developing culturally specific 
legislation to lessen the transgenerational impact of obesity. Though breastfeeding 
beneficial effects on infants’ weight fades after cofounder adjustments, nevertheless, 
xxi 
promoting breastfeeding is a proactive endeavour that may contribute to infants’ 





1.1 Background  
Maternal nutritional status before and during pregnancy dictates fetal 
adaptations at the earliest stages of the life-which can induce both short-term and long-
lasting effects on offspring (WHO, 2016). Much of human growth and development is 
completed during the first 1000 days extending from the intra-uterine life until two 
years of infancy (Groer et al., 2014; S. Robinson, 2015). A period of a child’s life is 
viewed as a critical “window of opportunity” for the acquisition of optimal growth, 
health, and curbing non-communicable disease (NCD). The Developmental Origins of 
Health and Disease (DoHaD) hypothesis was developed by Barker (Barker, 2007) and 
colleagues. It highlighted the link between prenatal, perinatal, and early postnatal 
exposure to certain environmental factors and subsequent development of obesity and 
non-communicable diseases. This epigenetics area has become one of the widespread 
and most complex areas of biological science (Patro et al., 2013; S. M. Robinson et 
al., 2015).  
There is an escalating prevalence of overweight and obesity worldwide (Afshin 
et al., 2015) and across all age groups (WHO, 2016). Recently, the World Health 
Organization (WHO) had reported that obesity prevalence tripled between 1975 and 
2016. The number of overweight adults worldwide has surpassed one billion, an 
estimated 39% of adults aged 18 years and over were overweight (39% of men and 
40% of women), about 13% of the world’s adult population (11% of men and 15% of 
women) were obese. The WHO had revealed that 41 million children under the age of 
2 
5 years as overweight or obese in 2016 (WHO, 2016) in high-income countries and 
low-and middle-income countries. Further, the global prevalence of childhood obesity 
has increased by more than 8 folds during the last four decades and continues to rise 
(Alshaikh et al., 2017).  
The Gulf Cooperation Council countries (GCC), including the United Arab 
Emirates (UAE), share this global obesity epidemiology. According to the WHO 2016- 
country profile of the UAE, obesity prevailed among 27% and 39% of males and 
females, respectively, 65 % and 13% of adolescent boys and girls. Accumulating 
epidemiological studies have identified excess weight as a risk factor for expanding 
the set of chronic diseases, including cardiovascular diseases, diabetes mellitus, 
chronic kidney disease, and many cancers (Mokdad et al., 2014). 
It is essential to highlight that women are more affected by obesity than men, 
as revealed by the WHO report (2016). Maternal obesity constitutes one of the most 
important women’s health issues and significant obstetric problems (Huda et al., 2010; 
Patro et al., 2013; Gaillard et al., 2016). Many systematic reviews ascertained that 
women who were overweight at conception, have nearly twice the risk of excessively 
gaining gestational weight compared to those with normal pre-pregnancy weight (E. 
A. Nohr et al., 2008; Vidakovic et al., 2015). Furthermore, excessive GWG increases 
the risk of greater postpartum weight retention (PPWR) (Riz et al., 2009; Goldstein et 
al., 2017) and gestational diabetes mellitus (GDM). Consequently, it increases the risk 
for life-long obesity, metabolic syndrome (MetS), cardiovascular diseases (R. Gaillard 
et al., 2016) and Type 2 diabetes mellitus (T2DM) (Kiel & Dodson, 2007; Schmatz et 
al., 2010). Consistent reports arise from GCC, a cross-sectional national study from 
Qatar (Al Thani et al., 2015)  revealed the same high-risk behaviors of elevated odds 
of MetS among Qatari women in their reproductive ages. At the same time, a recent 
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systematic review among women from the GCC showed that obesity and physical 
inactivity were part of the commonly reported risk factors for cardiovascular disease 
and T2DM, MetS and hypertension (Alshaikh et al., 2017).  
Furthermore, maternal adiposity in the antenatal period is associated with 
excessive placental nutrient transfer (Catalano & Shankar, 2017) and fetal over 
nutrition and fat accretion, which would be a major contributor to metabolic 
disturbances and macrocosmic babies. The effects of the maternal diet during 
pregnancy and lactation are critical for the mother and her infant's future metabolic 
health. They may be the key to attenuating the transgenerational risk of childhood 
obesity. In its position statement, the Academy of Nutrition and Dietetics (2014) 
recommended adherence to healthful dietary patterns, including the alternate 
Mediterranean Diet, Dietary Approaches to Stop Hypertension (DASH), and Alternate 
Healthy Eating Index, which has been associated with a 24% to 46% lower risk of 
GDM.  
The obesity epidemic is not merely a consequence of positive energy balance, 
but a multi-factorial condition of environmental, societal, biological, and genetic roots. 
Nevertheless, enlargement in fat white deposits triggers an inflammatory response 
associated with a higher metabolic rate. In the same context, pregnancy per se 
represents a physiological mild maternal systemic inflammatory state associated with 
oxidative stress and free radicals’ formations (Loy, S. L. & Jan Mohamed, 2014), 
which eventually becomes exaggerated in obese pregnant women (Bautista-Castaño et 
al., 2013). This ultimately leads to adipocyte dysfunction resulting in the dysregulated 
release of inflammatory modulator adipokines. 
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Adipokines are a group of protein hormones secreted by maternal adipose 
tissue. Some like adiponectin are found to be produced by the placenta (D’Ippolito et 
al., 2012) during pregnancy and umbilical plasma. They hence suggest a possible role 
on fetal development and metabolism. In adults, the circulating concentration of these 
proteins and hormones is linked to an individual’s body weight and BMI; leptin is 
secreted primarily by adipocytes in proportion to the total amount of body adipose 
tissue, therefore positively correlated with BMI (Eriksson et al., 2010).  
In contrast, adiponectin correlates negatively with adiposity and BMI and 
exhibits insulin-sensitizing, anti-atherogenic, fat-burning, and anti-inflammatory 
properties  (Arroyo-Jousse et al., 2020). Serum interleukin (IL-6), C-reactive protein 
(CRP), and tumor necrosis factor-α (TNF-α) are among the important and frequently 
examined proinflammatory cytokines in clinical settings, which are associated with 
excess fat mass (Pendeloski et al., 2017).  
Human milk, apart from the already known constituents of different nutrients, 
other biological compounds are uniquely expressed with the potential to influence 
infant growth and development. Examples of these cytokines and metabolic hormones 
are adiponectin, leptin, and insulin (Lönnerdal, 2010; Fields & Demerath, 2012). Of 
interest, adiponectin was detected in human milk (Martin L. J. et al., 2006) in 
concentrations higher than in circulation (F Savino et al., 2008). Further, CRP is a 
newly investigated breast milk component marker for obesity mediated inflammatory 
effects (McLachlan et al., 2006). When adiposity and pre-pregnancy BMI are taken 
into account, obese pregnant women exhibit higher levels of colostrum and serum CRP 
but lower levels of serum adiponectin (Whitaker et al., 2017).  
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The above-mentioned facts open breakthroughs in understanding the breast 
milk metabolic patterns and beneficial effects of breastfeeding arising from these 
biological compounds. These facts taken together, breastfeeding is beneficial through 
an epigenetic mark that is demonstrated to be dose-dependent (Mazzocchi et al., 2019; 
The Lancet’s Series, 2016). A surplus of epidemiological evidence supports the 
possible protective role of breastfeeding in the prevention of childhood overweight and 
adult obesity (Kramer & Kakuma, 2002; Perez-Escamilla, 2016). “Breastfeeding is an 
unequaled way of providing ideal food for the healthy growth and development of 
infants” (WHO, 2007) and “one of the most highly effective preventive measures a 
mother can make in protecting the health of her infant and herself is to breastfeed” 
(Shawar & Shiffman, 2017). 
Breastfeeding benefits extends to the mother as well. Women who consistently 
breastfeed have decreased visceral adiposity (intra-abdominal fat depots) and hence 
fewer risks of diabetes, cardiovascular disease, and metabolic syndrome (Zhu et al., 
2014; Castillo et al., 2016). 
1.2 Rationale  
During the past decades, UAE has witnessed profound socioeconomic 
transition and modernization in lifestyle, which fashioned food consumption patterns 
and lifestyle that led to obesity epidemics in the population (Al Dhaheri, S. et al., 2016; 
Aljefree & Ahmed, 2015). Physical inactivity and obesity are among the leading risk 
factors for CVD (38%, 30%), respectively (WHO, 2016). Besides, the population's 
tendency to develop obesity after marriage is evident, where more than 50% of the 
Emirati married population is obese (WHO, 2016). 
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The UAE’s 2021 vision has taken on the prevalence of diabetes, the majority 
of obesity amongst children, and the number of deaths due to cardiovascular diseases 
per 100,000 population, as its leading national performance indicators for world-class 
health care to guide targeted interventions and public health efforts (UAE Vision, 
2020). In 1992, the Ministry of Health in UAE had adopted the international 
recommendations of UNICEF/WHO to meet the “Baby-Friendly” standards for 
optimal breastfeeding-related to maternity care in all maternity hospitals. 
Pregnancy is a vulnerable period for increased weight gain, usually followed 
by higher postpartum weight retention, which initiates a vicious cycle of obesity 
among women during their reproductive years (Nehring et al., 2011). Consequently, it 
might contribute to adverse health trajectories recognized in offspring-early life and 
may have long-term consequences. Accordingly, exploring pregnant women's 
nutritional status is of precedence in the UAE and geared one of the study's aims. 
Given that obesity and pregnancy share metabolic patterns of systematic 
inflammation, it is interesting to explore the associations of circulatory inflammatory 
cytokines and adiponectin with maternal and infants’ adiposity. 
In addition, many authors and cohorts investigated the breast milk bioactive 
components and, in particular, the role of milk adiponectin in infant metabolic 
development. Yet, no study to date has examined breast milk components in the UAE.  
Considering the cumulative evidence of the possible protective aspect of 
breastfeeding in preventing childhood overweight and adult obesity (Horta et al., 
2007), and the current status of suboptimal breastfeeding feeding practices in the UAE 
(Radwan, 2013) investigating the link of adipokines among Emirati and Arab mothers 
and their infants is of great interest.  
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1.3 Significance of the Study 
Amidst these ongoing societal shifts and developments, this study aimed to address 
maternal and child nutrition and its associations with metabolic markers. A few 
cohorts have addressed antenatal nutrition and early life exposures and their impact 
on health outcomes in the Arab region. There is an undoubted need to identify early 
determinants of obesity in the Arab region (Al-Rifai et al., 2018). Obesity has 
significant health implications across multiple ages and populations and creates a 
substantial financial burden worldwide (Afshin et al., 2015). In the UAE, the cost of 
illness for diabetes per patient was estimated at $2,015 (adjusted for the year 2015), 
and it became twice and 6 times higher in patients with vascular complications 
(Radwan et al., 2018). Nevertheless, the Ministry of Health and Prevention, MoHAP, 
has acknowledged the country's health challenges and recently released the National 
Nutrition Guideline (The National Nutrition Guidelines - The Official Portal of the UAE 
Government, 2019). This endeavor was part of the country’s efforts to achieve the 
Sustainable Development objectives 2030 and find radical solutions to health 
situations—the Ministry of Health and Prevention. (2019, October 1).  
This study included a rich collection of predictors and confounding factors 
related to pregnant and lactating women, such as dietary intake and lifestyle as well as 
infant feeding practices. In addition, numerous maternal and infants’ biochemical 
variables were assessed, and their relationship with mothers’ postpartum weight and 
infant growth patterns were investigated. Collectively, this will serve as a primary 
database of pregnant and lactating mothers' status that will pave the way for national 
culture-specific interventions for the health of pregnant women and young children. 
From this perspective, it is hoped that revealing the potential role of pre-pregnancy 
overweight, breast milk adiponectin, and the duration of breastfeeding through this 
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study may help identify its relation to regulation of adiposity development among 
women and children through this study.  
1.4 Objectives 
1.4.1 General 
To investigate the role of maternal nutritional status and inflammatory markers 
on postpartum weight retention and on infant growth development during the first 6 
months of life through a prospective study. 
1.4.2 Specific 
i. To evaluate maternal nutritional status (pre-pregnancy BMI), dietary intake, 
lifestyle factors and gestational weight gain during pregnancy. 
ii. To investigate the associations of maternal breast milk adiponectin and C 
reactive protein (hs CRP) levels and maternal serum adipocytokines levels 
within the postpartum period. 
iii. To compare maternal serum lipid and glycemic profiles and adipocytokines 
with maternal weight status at 6 months postpartum. 
iv. To assess the associations of maternal factors (dietary intake, lactation status, 
serum adipocytokines) with mothers’ (PPWR) at 6 months postpartum. 
v. To compare infants’ anthropometry and serum adipocytokines levels with 
infants’ different feeding patterns at six (6) months of age. 
vi. To investigate the associations between infant’s feeding patterns, maternal 
serum and breast milk adipocytokines levels with infant adiposity at six (6) 
months of age. 
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1.5 Research Questions 
What is the maternal nutritional status, dietary intake, lifestyle factors, and 
gestational weight gain during pregnancy? 
Is there any association between maternal breast milk adiponectin and C 
reactive protein (hs CRP) levels with maternal serum adipocytokines levels within 
postpartum period after controlling the cofounders? 
Is there are any association between maternal factors (dietary intake, lactation 
status, serum adipocytokines) with mothers’ (PPWR) at 6 months postpartum after 
controlling the cofounders? 
Is there any difference in maternal lipid, glycemic profiles and serum 
adipocytokines among maternal different weight status at 6 months postpartum? 
Is there any difference in infants’ anthropometry and serum adipocytokines 
among infants with different feeding patterns at six (6) months of age? 
Is there an association between infant’s feeding patterns, maternal serum and 
breast milk adipocytokines with infant adiposity at 6 months of age after controlling 
the cofounders? 
1.6 Alternative Hypothesis  
Ha: Mothers who gained weight excessively during pregnancy would 
experience greater postpartum weight and body fat retention. 
Ha: Mothers with lower postpartum weights would have lower serum 
proinflammatory cytokines profile. 
Ha: Infants with different feeding patterns will exhibit different growth 
patterns.   
Ha: Infants who are breastfed will have lower serum proinflammatory 
cytokines profile.  
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Ha: Maternal breast milk adiponectin levels are associated with reduced infant 
adiposity development within 6 months of infants' age. 
1.7 Conceptual Framework  
The conceptual framework depicted in Figure 1.3 presents the study 
background and the hypothesized exposures, covariates, and outcomes.  
At the prenatal environment, this includes maternal pre-pregnancy adiposity, 
faulty dietary intake, sedentary lifestyle, dyslipidemia as well as excessive gestational 
weight gain. These conditions, consequently, prejudice metabolic dysregulation in the 
mothers and fetuses such as elevated maternal pro-inflammatory markers, insulin and 
depressed serum adiponectin. Knowing the role of adiponectin in glucose and fatty 
acids metabolism and in insulin sensitivity, the suppressed levels of maternal serum as 
well as the breast milk adiponectin, might promote adverse effects to the mothers and 
fetus, through alterations in insulin sensitivity and adiposity for both the mother during 
postpartum period and for the offspring later in life. 
Meanwhile, breastfeeding practices may also play a significant protective role 




Figure 1.1 Conceptual Framework 
 
1.8 Operational Definitions  
 Adipokines-Proteins that are secreted from (and synthesized) by adipocytes 
(include adiponectin and leptin). 
 At Birth-A follow-up visit, within (median=3, IQR=1-4) days after delivery; 
for the milk collection, within (median=3, IQR=1-5) days after delivery. 
 Cesarean Delivery-A delivery by a surgical procedure, in which one or more 
incisions are made through the mother's abdomen and uterus.  
 Excess Weight (prepregnancy BMI category)-Mothers with overweight and 
obese prepregnancy BMI status. 
 Gestational Age-A measure of the age of pregnancy in weeks, from the first 
day of the mother's last menstrual cycle to the current date. 
 Healthy Pregnancy-A pregnancy in the absence of pre-existing or currently 




 History of Chronic Diseases: diabetes, hypertension, kidney disease, cancer, 
or other chronic diseases), autoimmune disorders, or infections with the 
human immunodeficiency virus, or hepatitis in preconception. 
 Macrosomia-The birth weight of more than 4000g. 
 Low birth Weight (LBW)-The birth weight of less than 2500g. 
 Normal Delivery-A delivery through the vagina. 
 Parity-The number of >20 weeks birth, including stillborn. 
 Postpartum/ Postnatal Period-A period after delivery or birth; (postpartum 
is the term used for the mothers, while postnatal is the term used for the 
infants). 
 Prenatal factors Include maternal nutritional status, dietary intake, physical 
activity, physical discomforts, and lipid profiles. 
 Prenatal Period-A period during pregnancy before delivery or birth. 
 Term Delivery-A delivery between 37 and 42 weeks of gestation. 




2.1 Maternal Obesity  
Obesity is well defined by the World Health Organization as “ a clinical 
condition defined by an increase of adipose tissue that has a major impact on health 
and is one of the main risk factors for a variety of chronic diseases such as diabetes, 
hypertension, cardiovascular disease, and cancer” (WHO, 2011). 
It is essential to highlight that maternal obesity has the potential to cause an 
impact on the health of future generations (Moussa et al., 2016; Morais et al., 2019) 
whether through metabolic changes transmitted to the fetus during pregnancy or 
through the alterations in an infant’s nutritional programming (Bowen et al., 2002). 
Besides, obesity among pregnant women is a well-documented risk for mothers 
strongly associated with developing various maternal morbidities such as gestational 
hypertension and gestational diabetes (Arabin & Stupin, 2014; Erliana & Fly, 2019). 
On the other hand, higher placental transfer of the maternal nutrients and subsequent 
programming of offspring adiposity or potential cardiovascular and metabolic 
development originating from fetal life until adulthood (Arabin & Stupin, 2014). Apart 
from the metabolic complications, subfertility has also been recognized to be joined 
with obesity. Simultaneously, the increased likelihood of conception was correlated 
with weight reduction trials in obese infertile women (Moussa et al., 2016).  
Accruing evidence has shown that adiposity in pregnancy is the leading cause 
of maternal and fetal morbidity, excess gestational weight gain (GWG), metabolic 
dysregulation, especially gestational diabetes, risk of hypertension. In a contemporary 
study, maternal prepregnancy overweight and obesity were associated with offspring 
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earlier adiposity rebound 6-7 years of age (OR=1.07, 95% CI=1.02-1.11) and growing 
childhood obesity (Moussa et al., 2016). 
It is well documented that the drives towards obesity are much more 
complicated and multifactorial; these include an abundance of cheap, processed, 
energy-rich foods, oversized portions, and lifestyle factors characterized by reliance 
on technology. All these encourage less physical activity and reduce energy 
expenditure and promote an obesogenic environment. 
2.1.1 Prevalence of Obesity: the extent of the problem 
The growing dominance of maternal obesity worldwide to almost epidemic 
proportions in the last 20 years constitutes one of the most important women’s health 
issues. Besides, one of major obstetric problem of woman’s life in the antepartum, 
peripartum and postpartum periods (Huda et al., 2010; Poston et al., 2011). Among 
Westernized societies, data from Australia, America, and the United Kingdom reveals 
half of the women enter pregnancy with a BMI exceeding 25 kg/m2 (Li, NanLiu, et al., 
2013). In the USA, the prevalence of obese women of childbearing age increased four-
fold from 1976 to 2014, approaching 27.5% (Flegal & Larkin, 1990), while in the UK 
more than half of the deaths during late pregnancy or labor directly or indirectly 
occurring among overweight or obese women (Poston et al., 2011)  
Women of the Gulf countries have also been affected. Alhyas and colleague 
(Alhyas et al., 2011) explored 45 studies published between 1987 and 2010 that 
exposed high incidence of risk factors for diabetes and diabetic complications 
(hyperglycemia, hypertension and dyslipidemia in the GCC region and found the 
prevalence of overweight and obesity was relatively high in women with advancing 
age beyond 30 year. A latest review by Mashael K. Alshaikh (2017) identified 11 
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systematic reviews about women from GCC and reported alarming facts of female 
obesity approaching the highest global rates; ranges from 29 to 45.7%. The author 
linked the reasons for lifestyle changes such as physical inactivity (45 to 98.7%) and 
higher consumption of unhealthy foods. In this sense, pre-gravid overweight is also 
escalating to render it a common high-threat obstetric situation in the Gulf (Moussa et 
al., 2016). Married Saudi women (33.7%) has increased risk of obesity with age 
(Memish et al., 2014); further four years later, in the RAHMA cohort (Fayed et al., 
2017), the rate inflated and 65% of the nondiabetic women were either obese or 
overweight. GDM continued to be a risk factor for all adverse maternal and neonatal 
outcomes. In Qatar, another Gulf country, within 10 years period, women who had 
entered pregnancy with a pre-pregnancy BMI>25 Kg/m2 increased from 42.1% (Abu 
Yaacob et al., 2002) to 58%  (Abdulmalik et al., 2019) MINA cohort.  
2.1.2 Obesity and Inflammation 
Obesity and pregnancy have been contemplated as a physiological low-grade 
systemic inflammation status characterized by enlargement in white fat deposits. 
During pregnancy, the placenta produces a range of immunomodulatory hormones and 
cytokines. Maternal obesity with expanded adipocyte size upsurges pro-inflammatory 
cytokines; interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) (insulin 
resistance) and C-reactive protein (CRP) (Zavalza-Gómez et al., 2008); as well as 
decreased expression of adiponectin (insulin sensitivity), alterations in glucose and 
lipid metabolism, and energy balance and control of appetite (leptin) (Schmatz et al., 
2010). 
As such, the underlying pathophysiology linking adiposity and adverse 
pregnancy outcomes is complicated but is likely to involve cellular dysfunction and 
16 
dysregulated release of adipokines, which adversely affect placental and fetal 
development and long-term offspring cardio-metabolic health outcomes (Romy 
Gaillard et al., 2016) or increased mortality from cardiovascular events (Reynolds et 
al., 2013). 
Studies have demonstrated that metabolic changes due to maternal obesity can 
lead to changes in the constituents of colostrum and human milk, thereby modifying 
the different concentrations of hormones regulating appetite and metabolism, such as 
adiponectin and leptin, through breastfeeding (Bronsky et al., 2011; Fujimori et al., 
2017; Kugananthan et al., 2018). 
 
Figure 2.2  Maternal-Placental crosstalk and fetal growth adopted from Catalano, 
P. M., & Shankar, K. (2017). Obesity and pregnancy: mechanisms of short-term and 
long-term adverse consequences for mother and child. Bmj, 356, j1.(Catalano & 
Shankar, 2017).  
Despite comprehensive research in this area, the relationship between obesity 
in pregnancy or “maternal obesity” and inflammation to the moment is still unclear. 
This may be partly be due to the investigation of different inflammatory mediators in 
different periods of pregnancy. For instance, while several studies disclose possible 
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normal-weight women in the different trimester of pregnancy, others contradict these 
findings (Anderson et al., 2016; Pourvaghar et al., 2016; Fazeli Daryasari et al., 2019). 
2.2 Nutritional status during pregnancy 
2.2.1 Dietary intake during pregnancy 
Dietary behavior, energy and nutrient intakes during pregnancy are crucial for 
maternal and child health (Kominiarek & Peaceman, 2017; Richard I. Lowensohn, 
Diane D. Stadler, 2016) to support the growth of maternal and fetal tissues and to 
accumulate reserves for lactation. A substantial body of evidence ascertains maternal 
epigenetic influence on fetal programming, which describes the chemical 
communication between the mother and the fetus and the transgenerational influence 
which persist across the life course (Barker et al., 2002; Douglas et al., 2007). 
Most of the recent studies' interest in dietary intake during pregnancy stems 
from its direct relation with the global rise in obesity among women of reproductive 
age (Koletzko, Demmelmair, et al., 2019). Experts insist that there is no need to 
increase caloric intake in pregnancy, but rather to shift from energy-dense into more 
nutrient-dense calories nourishment is of particular importance (Kominiarek & 
Peaceman, 2017).  
There has been growing interest in examining the overall maternal diet quality, 
in exploring associations between whole foods and health status, rather than just 
nutrients (Doyle et al., 2017; Shapiro et al., 2016). Some authors used healthy adults' 
diet indices to assess the diet quality of pregnant women, such as the “Healthy Eating 
Index” (HEI-2005) and (HEI)-2010) (Shin et al., 2014). At the same time, authors 
modified the concept to suit the pregnancy population like “Alternate Healthy Eating 
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Index for Pregnancy (AHEI-P)”(Rifas-Shiman et al., 2009) and “Diet quality Index-
pregnancy” (DQI-P) (Crivellenti et al., 2018). The (HEI-SGP), of the Asian cohort 
study: Growing Up in Singapore Towards healthy Outcomes  (Chia et al., 2018; Han 
et al., 2015). Most of these specific indices have focused on certain nutrient adequacies 
such as folate and iron since their requirements are elevated before and during 
pregnancy to satisfy their own needs and optimize birth outcomes (Koletzko, 
Demmelmair, et al., 2019). 
An updated systematic review and meta-analysis (Schwingshackl et al., 2018) 
revealed high scores from Healthy Eating Index, the Alternate Healthy Eating Index, 
and the Dietary Approaches to Stop Hypertension were associated with a significantly 
lower risk of no communicable diseases in the long run. While other studies explored 
the relation of diet quality (DQ) with weight status and reported inverse association 
between pre-pregnancy weight status and diet quality, the Project Viva by (Rifas-
Shiman et al., 2009) (AHEI-P) and the Asian cohort study  (Chia et al., 2018) where 
older women had significantly higher AHEI-P scores.  
Further, adherence to a Mediterranean diet pattern during pregnancy was 
associated with lower incidence of GDM and better degree of glucose tolerance among 
women without GDM (Cucó et al., 2006) and adequate intake of fruits and vegetables 
were associated with birth size and length (See Ling Loy et al., 2011) while lower 
weekly intakes of vegetables was observed among overweight or obese Egyptian 
pregnant (Hassan et al., 2016).  
On the other hand, some studies revealed inadequacy in key nutrients such as 
folate, vitamins A and D, iron, calcium, and zinc among Iranian pregnant  
(Esmaillzadeh et al., 2008) and in food group servings like milk and alternatives, 
vegetables and fruit, and meat (Fowles et al., 2006) (Fowler et al., 2012) , which are 
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sources for these essential micronutrients. Consistent to Western findings, of the scarce 
studies in Arab pregnant, the DEPOSIT cohort, in adequacy of complete protein, 
dietary fiber, Zn, was among 50% of Palestinian Bedouin women’s usual dietary intake 
and almost 95% had inadequate of vitamin A, calcium and folate  (Abu-Saad et al., 
2012). 
2.2.2 Gestational weight gain 
Weight gain is crucial for optimal outcomes for both mothers and infants 
(Merchant et al., 1999). Many factors influence variation in pregnancy weight gain, 
however, impact of pre-pregnancy body mass index (BMI), remained a major 
predictor. With this conception the Institute of Medicine (IOM), (now renamed as the 
National Academy of Medicine) has set the guidelines for GWG according to pre-
pregnancy BMI in 1990 and revised it in 2009 (Siega-Riz et al., 2009). Previous 
systematic narrative reviews (Marchi et al., 2015), and meta-analysis (Ma et al., 2015), 
confirmed the predicting effects of excessive gestational weight gain; such as 
gestational diabetes, pre-eclampsia, gestational hypertension, depression, instrumental 
and caesarean birth compared with healthy weight women. On the other hand, 
excessive GWG during early pregnancy was associated with an increased risk of 
gestational hypertension and preeclampsia, caesarean delivery, macrosomia, and 
postpartum weight retention after delivery (Ferraro et al., 2012; Ma et al., 2015; 
Yeşilçiçek Çalik et al., 2018). 
 Furthermore, excessive GWG was found to exacerbate the generational impact 
of obesity, whereby women who exceed the recommended weight gain during 
pregnancy are more likely to retain weight post-partum and to enter the next pregnancy 
with a higher BMI (Goldstein et al., 2017, 2018a). Most probably will deliver heavier 
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babies, who have higher odds to become overweight or obese adults later in life 
(Goldstein et al., 2017).  
On the other hand, limited GWG less than the recommendations were found to 
be associated with stillbirth, infant death, and child impaired neurocognitive or 
development behavior (Bodnar & Siega-Riz, 2002). At the infant level, maternal 
obesity and or underweight is also linked to greater risk of large for  gestational age 
babies, and preterm birth or small for gestational age (SGA) and sometimes perinatal 
death, (Xie et al., 2016) . Another obstetric issue is retention of the excess body weight 
gained with each pregnancy as revealed in many systematic and meta-analysis reviews 
(Nehring et al., 2011;Ma et al., 2015), and might be associated with the added burden 
of chronic diseases (Rong et al., 2015). Besides, the increased maternal fat deposition 
may lead to the higher placental transfer of nutrients, and consequently, significantly 
higher infants BMI Z-score (Li, NanLiu et al., 2013).  
The mechanisms of these associations remain unclear, as gestational weight 
gain reflects both maternal nutritional status as well as tissue expansion during 
pregnancy, because of fat storage and fluids (Siega-Riz et al., 2009). GWG is 
comprised of the accretion of water, protein fat free mass (FFM) and fat mass (FM) in 
the fetus as well as the placenta, uterus and amniotic fluid, expansion of maternal blood 
volume, mammary gland and maternal adipose tissue (Brown, Judith. E. ,Murtaugh, 
Maureen. A.,Jacobs Jr.David, R., and Margellos, Helen, 2002; Potdar et al., 2014). The 
fat that is gained during pregnancy is preferentially deposited on the trunk and thighs. 
2.3 Adipocytokines  
Adipokines and cytokines , collectively are group of bioactive adipokines and 
cytokines produced mainly by adipocytes are recently gaining researches observation 
(D’Ippolito et al., 2012; Ohashi et al., 2012; Sahin-Efe et al., 2012). The most 
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frequently investigated adipokines are adiponectin and leptin; while inflammatory 
mediated cytokines are tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), 
plasminogen activator inhibitor-1, and Resistin. They are secreted by maternal tissues, 
umbilical plasma and cord blood  (Ohashi et al., 2014).  
2.3.1 Adiponectin 
Adiponectin is an adiposecreted proteins termed adipocytokine, a hormone 
produced predominantly by adipose tissue, initially discovered and described by 
Scherer et al. (1995) as ACRP (adipocyte complement-related protein of 30 kDa). It is 
a 224 amino acid peptide, expressed in adipose tissue and has two different receptors: 
Adipo-R1 is abundantly expressed in skeletal muscle, while Adipo-R2 is 
predominantly expressed in the liver (Kubota et al., 2007). Adiponectin (ADPN) 
circulates in very high concentrations in human serum and it is present as three main 
isomeric forms: trimeric low molecular weight (LMW), hexameric medium molecular 
weight (MMW) and high molecular weight (HMW). The high molecular weight 
multimers accounts for approximately 50% of the total ADPN in human circulation, 
available in the micrograms per milliliters range (plasma concentration is 5–10 μg/mL) 
(Halberg et al., 2009) and considered as the most active forms of protein in control of 
metabolic processes (Halberg et al., 2009; Ohashi et al., 2014; Steinberg & Kemp, 
2007). In humans, it has been consistently shown that low circulating levels of ADPN 
are associated with obesity, type 2 diabetes mellitus (T2DM), and cardiovascular 
disease (CVD) (Arita et al., 1999; Calle & Fernandez, 2012; Falahi et al., 2015).  
Adiponectin demonstrates a vital role in regulating energy metabolism, 
improve insulin sensitivity, stimulate glucose uptake and fatty acid oxidation and 
inhibit liver gluconeogenesis (Pfützner et al., 2010). At the peripheral level, such as in 
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skeletal muscle, adiponectin enhances AMP-activated protein kinase (AMPK) 
activity, and directly stimulates the glucose uptake in muscle and adipocytes and 
stimulates fatty acid oxidation. Consequently, this process increases mitochondrial β-
oxidation and decreases the circulating free fatty acids which results in decreased 
triglyceride concentration in muscle and hence leads to improvement in insulin 
sensitivity (Hoffstedt et al., 2004). While in the liver, triggered (AMPK) activity leads 
to the suppression of hepatic gluconeogenesis (Maiorana et al., 2007). 
It was also revealed that adiponectin has anti-atherogenic properties (Arita et 
al., 1999; Ouchi et al., 2003; Skrabal et al., 2011) and attenuates adhesion of 
monocytes to surface of activated endothelial cells (Kubota et al., 2007). In a study by 
(Ohashi et al., 2012) among Japanese men, low concentration of plasma adiponectin 
(<4.0 g/mL) exhibited an independent risk factor with a 2-fold increase in coronary 
artery disease. Furthermore, circulating adiponectin demonstrated significant negative 
association with some metabolic syndrome components (Kubota et al., 2007; 
Weyermann et al., 2006) documenting its anti-inflammatory preventive role. Several 
lines of evidence and recent systematic reviews (Torre-Villalvazo et al., 2018), 
suggested that low HMW adiponectin described as (hypoadiponectinemia, <2.5 
mg/ml) is considered as the most reliable biomarker for MetS diagnosis criteria. 
Adiponectin levels are mainly inversely associated with visceral fat, total body fat, 
body mass index (BMI), and waist circumference (Fuglsang et al., 2010). Hence there 
is reduced release of adiponectin by the abdominal visceral adipocytes (VAT) the 
metabolically active adipose tissue despite fact that it is abundantly and solely 
synthesized in adipose tissue (Hocking et al., 2013). Hoffstedt et al  (2004) measured 
adiponectin adipose tissue secretion rate per weight unit in obese subjects and noticed 
reduced secretion rate by 30% (P<0.05) (Hoffstedt et al., 2004). In support of the 
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clinical findings, some experimental studies with mice have exhibited that adiponectin 
deficiency contributes to the development of obesity related diseases including insulin 
resistance, and cardiac diseases.  
 
Figure 2.3 Adiponectin Sites of Action (This figure summarizes the main 
actions of ADPN and their receptors (Adipo-R1and Adipo-R2) in different tissues) 
(Orlando et al., 2019).  
Consistent with adults, studies among children and adolescents of different 
ethnicity in Chinese  (Wen et al., 2014) and Italian cohorts (Nigro et al., 2017) and 
Brazilian adolescents (Sparrenberger et al., 2019) findings revealed lower 
adiponectin concentrations are associated with metabolic risk factors 
(atherosclerosis, waist circumference, triglycerides, total cholesterol, LDL-
cholesterol, fasting glucose levels, and insulin resistance)(Medina-Bravo et al., 
2011). 
The trajectory of adiponectin concentrations throughout pregnancy and in the 
postpartum period has been explored by several authors (Lacroix et al., 2013; 
McLachlan et al., 2006; Noureldeen et al., 2014). As reported in previous literature, 
pregnancy is a naturally mild maternal systemic inflammation state, that shares a 
pattern of insulin resistance with obesity (Catalano & Shankar, 2017; Romy Gaillard 
et al., 2016; Hrolfsdottir et al., 2016; Poston et al., 2011). As pregnancy progresses 
elevated secretion of inflammatory adipokines from maternal adipose tissue and 
placenta in late pregnancy along with the placental hormones such as human placental 
↓ Lipid oxidation 
↑ Triglycerides ↓ Glucose uptake  ↑inflammation markers 
 Weight excess 
 Insulin resistance 
 Endothelial dysfunction 
 hypertension 
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lactogen and placental growth hormones, (Fuglsang et al., 2010; Valsamakis et al., 
2010) furnish an insulin resistance environment in an attempt to enhance the 
availability of glucose for fetal needs. Longitudinal studies during pregnancy, among 
healthy pregnant mothers documented the decreasing pattern of ADPN concentration 
with advancing gestation, and generally accompanied by a decreased insulin 
sensitivity. Other authors reported hypoadiponectinemia to be more pronounced 
among GDM pregnant at their third trimester compared to(Vitoratos et al., 2008) 
normal  (Fujimori et al., 2017; Noureldeen et al., 2014; Siddiqui et al., 2018;) 
pregnancy  (Fujimori et al., 2017; Noureldeen et al., 2014; Siddiqui et al., 2018; 
Vitoratos et al., 2008).  
The production of adiponectin in the placenta and the fetus has suggested that 
adiponectin might have an important role in fetal and postnatal development 
(Weyermann et al., 2006). Some authors found a positive association between cord 
blood adiponectin levels with infant birth outcomes (weight, BMI percentiles, and lean 
body mass) (Cekmez et al., 2011; Jacques et al., 2016), while others have not (Bozzola 
et al., 2010; Lindsay et al., 2003). Lower adiponectin levels were found in the 
umbilical cord blood of neonates born to diabetic mothers (Cekmez et al., 2011) and  
in newborns born with large for gestational age (LGA) weights (29.4 ± 13.8 vs 35.0 ± 
9.9 μg/mL, P< .04) compared to newborns with weights adequate for gestational age 
(AGA) (Challa et al., 2005). However, earlier studies failed to show differences at two 
years of children age (Iñiguez et al., 2004). 
2.3.2 Adiponectin in breast milk 
Adiponectin apart from the main secretion source, evidence demonstrated its 
synthesis in salivary gland and mammary epithelial cells. In 2006 adiponectin was 
